NICOLAS, DETERRED and KEYNOTE 799: focus on escalation of conventionally fractionated chemoradiotherapy by immune checkpoint inhibition in unresectable stage III non-small cell lung cancer

Detalles Bibliográficos
Autores principales: Manapov, Farkhad, Kenndoff, Saskia, Käsmann, Lukas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2022
Materias:
Letter to the Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9073737/
https://www.ncbi.nlm.nih.gov/pubmed/35529786
http://dx.doi.org/10.21037/tlcr-21-950
_version_ 1784701352766603264
author Manapov, Farkhad
Kenndoff, Saskia
Käsmann, Lukas
author_facet Manapov, Farkhad
Kenndoff, Saskia
Käsmann, Lukas
author_sort Manapov, Farkhad
collection PubMed
description
format Online
Article
Text
id pubmed-9073737
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher AME Publishing Company
record_format MEDLINE/PubMed
spelling pubmed-90737372022-05-07 NICOLAS, DETERRED and KEYNOTE 799: focus on escalation of conventionally fractionated chemoradiotherapy by immune checkpoint inhibition in unresectable stage III non-small cell lung cancer Manapov, Farkhad Kenndoff, Saskia Käsmann, Lukas Transl Lung Cancer Res Letter to the Editor AME Publishing Company 2022-04 /pmc/articles/PMC9073737/ /pubmed/35529786 http://dx.doi.org/10.21037/tlcr-21-950 Text en 2022 Translational Lung Cancer Research. All rights reserved. https://creativecommons.org/licenses/by-nc-nd/4.0/Open Access Statement: This is an Open Access article distributed in accordance with the Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International License (CC BY-NC-ND 4.0), which permits the non-commercial replication and distribution of the article with the strict proviso that no changes or edits are made and the original work is properly cited (including links to both the formal publication through the relevant DOI and the license). See: https://creativecommons.org/licenses/by-nc-nd/4.0 (https://creativecommons.org/licenses/by-nc-nd/4.0/) .
spellingShingle Letter to the Editor
Manapov, Farkhad
Kenndoff, Saskia
Käsmann, Lukas
NICOLAS, DETERRED and KEYNOTE 799: focus on escalation of conventionally fractionated chemoradiotherapy by immune checkpoint inhibition in unresectable stage III non-small cell lung cancer
title NICOLAS, DETERRED and KEYNOTE 799: focus on escalation of conventionally fractionated chemoradiotherapy by immune checkpoint inhibition in unresectable stage III non-small cell lung cancer
title_full NICOLAS, DETERRED and KEYNOTE 799: focus on escalation of conventionally fractionated chemoradiotherapy by immune checkpoint inhibition in unresectable stage III non-small cell lung cancer
title_fullStr NICOLAS, DETERRED and KEYNOTE 799: focus on escalation of conventionally fractionated chemoradiotherapy by immune checkpoint inhibition in unresectable stage III non-small cell lung cancer
title_full_unstemmed NICOLAS, DETERRED and KEYNOTE 799: focus on escalation of conventionally fractionated chemoradiotherapy by immune checkpoint inhibition in unresectable stage III non-small cell lung cancer
title_short NICOLAS, DETERRED and KEYNOTE 799: focus on escalation of conventionally fractionated chemoradiotherapy by immune checkpoint inhibition in unresectable stage III non-small cell lung cancer
title_sort nicolas, deterred and keynote 799: focus on escalation of conventionally fractionated chemoradiotherapy by immune checkpoint inhibition in unresectable stage iii non-small cell lung cancer
topic Letter to the Editor
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9073737/
https://www.ncbi.nlm.nih.gov/pubmed/35529786
http://dx.doi.org/10.21037/tlcr-21-950
work_keys_str_mv AT manapovfarkhad nicolasdeterredandkeynote799focusonescalationofconventionallyfractionatedchemoradiotherapybyimmunecheckpointinhibitioninunresectablestageiiinonsmallcelllungcancer
AT kenndoffsaskia nicolasdeterredandkeynote799focusonescalationofconventionallyfractionatedchemoradiotherapybyimmunecheckpointinhibitioninunresectablestageiiinonsmallcelllungcancer
AT kasmannlukas nicolasdeterredandkeynote799focusonescalationofconventionallyfractionatedchemoradiotherapybyimmunecheckpointinhibitioninunresectablestageiiinonsmallcelllungcancer

Ejemplares similares